Title : Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer.

Pub. Date : 2020 Sep 15

PMID : 32571788






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The effect of the PARP inhibitor olaparib was assessed in vitro, using cultured circulating tumor cells (CTCs) from a patient with a somatically acquired BRCA1 mutation and a second patient with an acquired BRCA2 mutation. olaparib collagen type XI alpha 2 chain Homo sapiens